AHR and chronic kidney disease: HIFs and AHR contribute to the regulation of metabolism, lipolysis, inflammation, endothelial dysfunction, thrombosis, and tissue injury that variously manifest in complications of tissue ischemia, insulin resistance, thrombosis, and fibrosis in CKD.